Carville working with PRaVDA
PRaVDA (Proton Radiotherapy Verification and Dosimetry Applications) is a team of leading instrumentation engineers and scientists, medical, high-energy and nuclear physicists and oncologists from the Universities of Birmingham, Lincoln, Liverpool and Surrey, the University Hospitals Birmingham NHS Foundation Trust and the University Hospitals Coventry and Warwickshire NHS Trust, the iThemba Laboratories (Cape Town, South Africa).
Radiotherapy is a fundamental weapon in the battle against cancer with some 40% of patients receiving it as part of their treatment. Proton therapy enables a lower integrated radiation dose to a patient receiving radiotherapy (compared to x-rays) due to the finite range of protons and so allows more accurate targeting of the dose.
This three-year adventurous project brings together the UK’s leading detector and instrumentation scientists together with medical physicists and oncologists in close partnership with industry and other stakeholders. PRaVDA has use of the UK’s only research proton facility for extensive testing, and guaranteed access to other cyclotrons at key Proton Therapy treatment centres; together with unique skills in designing novel detectors that lie at the heart of PRaVDA.
For more information about PRaVDA, please visit;
June 14, 2015